According to a case study of Cleveland Clinic, an old man of 67 years suffering from transitional cell carcinoma of the bladder and ureter and adenocarcinoma of the prostate needed the removal of the right kidney, one-third of the bladder, one-third of the ureter, and the prostate. Interestingly, the whole surgery was successfully performed in six hours through a robotics-assisted procedure.
In February 2019, the U.S. Food and Drug Administration (FDA) revealed their skeptical attitude to leverage robotics-assisted surgical devices for women's health including mastectomy and other cancer-related Surgeries. It has also recommended the patients to gather proper knowledge about the benefit and risks of alternative treatment methods and to ask the surgeon about his or her training and experience in dealing with these advanced gadgets.
The presence of these two conflicting attitudes regarding the robotic-assisted surgery has generated confusions in the mind of patients, but without any doubt, it can be expected, the advent of technological advancements and its wide acceptability will become an essential factor to popularize surgical robots.
Keeping with the radical changes, the healthcare sector has become more interested in providing more efficient, personalized, and cost-effective service to their customers and the surgical robots with the ability to analyze massive data sets to find out the vulnerability and weak-point of an individual patient have turned into a vital weapon to the healthcare service providers to achieve desired precision. For example, the da Vinci surgical system mostly serves its goal of helping surgeons to deal with complicated cases in more precise and efficient manner, and more than 50 states leverage this innovative platform after its clearance from FDA.